Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial-Reference-Cited by-同舟云学术

Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial

Published:1998-07 Issue:1 Volume:29 Page:129-134
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Pelletier Gilles,Ducreux Michel,Gay France,Luboinski Monique,Hagège Herve,Thong Dao,Van Steenbergen Werner,Buffet Catherine,Rougier Philippe,Adler Michael,Pignon Jean-Pierre,Roche Alain

Publisher

Elsevier BV

Subject

Hepatology

Reference19 articles.

1. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma;N Engl J Med,1995

2. Comparison of resection, liver transplantation and transcatheter oily chemoembolization in the treatment of hepatocellular carcinoma;Bronowicki;J Hepatol,1996

3. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma;Pelletier;J Hepatol,1990

4. Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil;Kasugai;Gastroenterology,1989

5. Bile duct cysts secondary to liver infarcts: report of a case and experimental production by small vessel hepatic artery occlusion;Doppman;Radiology,1985

Cited by 361 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Embolization alone is as effective as TACE for unresectable HCC: systematic review and meta-analysis of randomized controlled trails;BMC Gastroenterology;2024-06-07

2. S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Kurzversion;Zeitschrift für Gastroenterologie;2024-02

3. S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Langversion 4.0;Zeitschrift für Gastroenterologie;2024-02

4. S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Kurzversion;Zeitschrift für Gastroenterologie;2024-01

5. S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Langversion 4.0;Zeitschrift für Gastroenterologie;2024-01